Xiaojia Liu

1.9k total citations
65 papers, 1.4k citations indexed

About

Xiaojia Liu is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Xiaojia Liu has authored 65 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 28 papers in Molecular Biology, 16 papers in Oncology and 13 papers in Immunology. Recurrent topics in Xiaojia Liu's work include Cancer Immunotherapy and Biomarkers (7 papers), RNA modifications and cancer (6 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Xiaojia Liu is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), RNA modifications and cancer (6 papers) and Genomics, phytochemicals, and oxidative stress (4 papers). Xiaojia Liu collaborates with scholars based in China, Macao and United States. Xiaojia Liu's co-authors include Hongbin Deng, Danqing Song, Mingxiao Yin, Qingxuan Zeng, Jingwen Dong, Genxiang Mao, Yang Liu, Jianxiu Yu, Ran Chen and Xian Zhao and has published in prestigious journals such as Nucleic Acids Research, Nature Communications and SHILAP Revista de lepidopterología.

In The Last Decade

Xiaojia Liu

60 papers receiving 1.4k citations

Peers

Countries citing papers authored by Xiaojia Liu

Since Specialization

Citations

This map shows the geographic impact of Xiaojia Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojia Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojia Liu more than expected).

Fields of papers citing papers by Xiaojia Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaojia Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojia Liu. The network helps show where Xiaojia Liu may publish in the future.

Co-authorship network of co-authors of Xiaojia Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojia Liu. A scholar is included among the top collaborators of Xiaojia Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojia Liu. Xiaojia Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Nonlinear relationship between BMI and 30-day in-hospital mortality in ICU sepsis patients: a multicenter retrospective cohort study 2025 ·BMC Infectious Diseases ·(unknown), (unknown), Xiaojia Liu, Li Zhou, Zhe Deng	0
2	Micro-lymphatic invasion impact prognosis of intrahepatic cholangiocarcinoma independent of lymph node metastasis and micro-vascular invasion 2025 ·European Journal of Surgical Oncology ·(unknown), Ying Zhu, Haoting Sun, Xiaojia Liu, (unknown), Jingwei Luo, (unknown), Baobing Yin	0
3	Loss of Fbxo45 in AT2 cells leads to insufficient histone supply and initiates lung adenocarcinoma 2024 ·Cell Death and Differentiation ·(unknown), Jiayong Li, Ran Chen, (unknown), Yong Zuo, (unknown), Xiaojia Liu, Jiayi Huang, Yanli Wang, (unknown), Jinke Cheng, (unknown), Chunling Du, Jianxiu Yu	2
4	The Relationship between Muscle Ultrasound Parameters and Diabetic Peripheral Neuropathy among Patients with Type 2 Diabetes Mellitus: A Cross-Sectional Study 2023 ·Journal of Diabetes Research ·(unknown), Xiaojia Liu, (unknown)	0
5	USP7 reduces the level of nuclear DICER , impairing DNA damage response and promoting cancer progression 2023 ·Molecular Oncology ·Xiaojia Liu, (unknown), Qianqian Yang, Jianfeng He, (unknown), (unknown), Zihan Zhou, Jiayi Huang, Lian Li, Ran Chen, Yanli Wang, Jian Huang, Ruiyu Xie, (unknown), Jianxiu Yu	6
6	Raddeanin A Enhances Mitochondrial DNA‐cGAS/STING Axis‐Mediated Antitumor Immunity by Targeting Transactive Responsive DNA‐Binding Protein 43 2023 ·Advanced Science ·Mingxiao Yin, Jingwen Dong, Cuicui Sun, Xiaojia Liu, Zhirui Liu, Lu Liu, (unknown), Na Zhang, Dian Xiao, Xinbo Zhou, Hongbin Deng	33
7	USP2 promotes tumor immune evasion via deubiquitination and stabilization of PD-L1 2023 ·Cell Death and Differentiation ·(unknown), Xiaojia Liu, Na Zhang, Jingwen Dong, Cuicui Sun, Mingxiao Yin, Yuting Wang, Lu Liu, Dian Xiao, Xinbo Zhou, Yanchun Feng, Danqing Song, Hongbin Deng	34
8	Baicalin circumvents anti-PD-1 resistance by regulating the gut microbiota metabolite short-chain fatty acids 2023 ·Pharmacological Research ·Yu Zhang, Xiaojia Liu, (unknown), Jian Zhang, (unknown), Jing Wang, Lin Yang, (unknown), (unknown)	32
9	Novel Small-Molecule PD-L1 Inhibitor Induces PD-L1 Internalization and Optimizes the Immune Microenvironment 2022 ·Journal of Medicinal Chemistry ·Chengliang Sun, Mingxiao Yin, Yao Cheng, (unknown), Xiaojia Liu, Gefei Wang, Xiao Wang, Kai Yuan, Wenjian Min, Jingwen Dong, Yi Hou, (unknown), Guoyu Zhang, (unknown), Liping Wang, (unknown), Xinmiao Yu, Yibei Xiao, Hongbin Deng, Peng Yang	33
10	Novel phthalimides regulating PD-1/PD-L1 interaction as potential immunotherapy agents 2022 ·Acta Pharmaceutica Sinica B ·Chengliang Sun, Yao Cheng, Xiaojia Liu, Gefei Wang, Wenjian Min, Xiao Wang, Kai Yuan, Yi Hou, Jiaxing Li, Haolin Zhang, (unknown), Liping Wang, Chenguang Lou, (unknown), Xinmiao Yu, Hongbin Deng, Yibei Xiao, Peng Yang	25
11	Exosomal MMP-1 transfers metastasis potential in triple-negative breast cancer through PAR1-mediated EMT 2022 ·Breast Cancer Research and Treatment ·(unknown), Zhonghua Tao, Ying Chen, Shuchen Lin, Mingyu Zhu, Wei Ji, Xiaojia Liu, Ting Li, Xichun Hu	35
12	Berberine Directly Targets the NEK7 Protein to Block the NEK7–NLRP3 Interaction and Exert Anti-inflammatory Activity 2020 ·Journal of Medicinal Chemistry ·Qingxuan Zeng, Hongbin Deng, Yinghong Li, Tianyun Fan, Yang Liu, Sheng Tang, Wei Wei, Xiaojia Liu, Xixi Guo, Jian‐Dong Jiang, Yanxiang Wang, Danqing Song	76
13	Upregulation of caprin1 expression is associated with poor prognosis in hepatocellular carcinoma 2017 ·Pathology - Research and Practice ·Ning Tan, Ling Dai, Xiaojia Liu, Guangdong Pan, Hui Chen, Jiang Huang, Qing Xu	21
14	Anti-N-methyl-d-aspartate receptor encephalitis associated with intracranial Angiostrongylus cantonensis infection: a case report 2016 ·Neurological Sciences ·Peng Yu, Xiaojia Liu, Suyue Pan, (unknown), Honghao Wang	13
15	Chemokine Expression Profiles of Human Hepatoma Cell Lines Mediated by Hepatitis B Virus X Protein 2015 ·Pathology & Oncology Research ·(unknown), Li‐Ping Zou, Xiaojia Liu, Hongguang Zhu, Rong Zhu	8
16	Hepatitis B virus X protein induces the histone H3 lysine 9 trimethylation on the promoter of p16 gene in hepatocarcinogenesis 2015 ·Experimental and Molecular Pathology ·(unknown), Li‐Ping Zou, Xiaojia Liu, Hongguang Zhu, Rong Zhu	14
17	Characteristics of dyslexia and dysgraphia in a Chinese patient with semantic dementia 2014 ·Neurocase ·Xiaoqin Wu, Xiaojia Liu, (unknown), (unknown), Yawei Zhang	5
18	The Results of 28 Patients with Pleural Effusion of Lung Cancer Treated with Brucea Javanice Oil Emulsion Combined with Bleomycin Hydrochloride for Injection 2012 ·Xiaojia Liu	1
19	[Pharmacokinetics of amphotericin B in the cerebrospinal fluid during continuous intrathecal administration for treatment of cryptococcal neoformans meningitis]. 2011 ·PubMed ·Min Fang, (unknown), Yuan Yan, Shiting Liu, Wenhui Gao, Xiaojia Liu, Yin Jia, Li Wang, Yuan-yuan Wang	1
20	Reliability and validity of Chinese version of the multiple sclerosis quality of life-54 questionnaire 2009 ·Zhonghua xingwei yixue yu naokexue zazhi ·(unknown), Xiaojia Liu, Xinyu Wang, (unknown)	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact